Mirum outlines $630M-$650M 2026 revenue target as pipeline advances toward four pivotal readouts
Source: SeekingAlpha
2026-02-25 18:38:42 ET
More on Mirum Pharmaceuticals
- Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call Transcript
- Mirum Pharmaceuticals, Inc. (MIRM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Mirum Pharmaceuticals: Rich In 2025, Richer (In Promise) In 2026? I Believe So
- Mirum Pharmaceuticals Q4 2025 Earnings Preview
- Mirum Pharmaceuticals to raise $68.5M in private placement with TCGX
Read the full article on Seeking Alpha
For further details see:
Mirum outlines $630M-$650M 2026 revenue target as pipeline advances toward four pivotal readouts
Mirum Pharmaceuticals Inc.
NASDAQ: MIRM
MIRM Trading
2.72% G/L:
$89.53 Last:
255,649 Volume:
$88.05 Open:
MIRM Latest News
March 05, 2026 08:00:00 am
Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
MIRM Stock Data
$5,184,583,745
44,013,457
0.43%
119
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
